Mridula George, Md

This study is testing a combination of two chemotherapy drugs (liposomal doxorubicin and carboplatin) given after surgery for early-stage triple-negative breast cancer (TNBC). The main goal is to see if this treatment can lower the chance of the cancer returning. Researchers will…